Integrating Quality Control: Studies of CHIP in Age-related Neurodegeneration

整合质量控制:CHIP 在年龄相关神经退行性疾病中的研究

基本信息

  • 批准号:
    8115917
  • 负责人:
  • 金额:
    $ 29.42万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-09-15 至 2014-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): As humans live longer, age-related neurodegenerative disorders caused by the accumulation of abnormal proteins are becoming increasingly common. In all cells, a protein quality control network (PQC) exists to "handle" such abnormal proteins arising from mutations, environmental stressors or the aging process. The selective brain vulnerability in age-related neurodegenerative disorders, however, suggests there is something unique about PQC in the brain that makes this organ particularly susceptible to misfolded proteins. Unfortunately, which PQC components are most important in the brain and how these components respond when exposed to abnormal proteins remain unknown. The studies proposed here will systematically explore changes in PQC that occur when aggregation-prone proteins are expressed in brain and will define mechanistically how a key PQC ubiquitin ligase, CHIP, handles neurodegenerative disease proteins. The underlying hypothesis is twofold: 1) PQC in the brain fails to keep pace with mounting proteotoxic stress during age-related neurodegeneration; and 2) the brain's PQC response to proteotoxic stress relies heavily on CHIP, a multifunctional protein that mediates crosstalk between chaperone- and ubiquitin-dependent pathways. In three Aims that build off the investigators' expertise in polyglutamine neurodegeneration and ubiquitin ligase biology, we will use complementary genetic and biochemical techniques to map basal and adaptive PQC changes in the aging mouse brain and in mouse models of polyglutamine neurodegenerative disease, both in the presence and absence of CHIP. Additional studies will determine the mechanisms by which CHIP ligase complexes are regulated in brain. The proposed studies will identify key PQC components that act on abnormally folded protein in the CNS and provide insights into their mechanisms of action. The results are expected to suggest targets for therapeutic strategies in a wide range of age-related neurodegenerative disorders. PUBLIC HEALTH RELEVANCE: Many common, incurable brain diseases that develop as people get older are associated with abnormal protein deposits in the brain. This proposal seeks to understand and define the "quality control" machinery inside brain cells that counteracts these abnormal proteins. Understanding this machinery may suggest routes to therapy for a large range of sporadic and hereditary neurodegenerative diseases that occur as we age.
描述(申请人提供):随着人类寿命的延长,由异常蛋白质积累引起的与年龄相关的神经退行性疾病变得越来越常见。在所有细胞中,都存在一个蛋白质质量控制网络(PQC)来“处理”这些因突变、环境压力或衰老过程而产生的异常蛋白质。然而,与年龄相关的神经退行性疾病的选择性大脑脆弱性表明,大脑中的PQC有一些独特的东西,使这个器官特别容易受到错误折叠的蛋白质的影响。不幸的是,大脑中哪些PQC成分最重要,以及这些成分在接触到异常蛋白质时如何反应仍是未知的。这里提出的研究将系统地探索当易于聚集的蛋白在大脑中表达时发生的PQC的变化,并将从机制上定义关键的PQC泛素连接酶CHIP如何处理神经退行性疾病蛋白。潜在的假设有两个:1)在与年龄相关的神经退化过程中,大脑中的PQC未能跟上日益增加的蛋白毒性应激的步伐;2)大脑对蛋白毒性应激的PQC反应严重依赖于ChIP,这是一种多功能蛋白质,在伴侣依赖和泛素依赖的通路之间介导串扰。在建立研究人员在多谷氨酰胺神经变性和泛素连接酶生物学方面的专业知识的三个目标中,我们将使用互补的遗传和生化技术来绘制在存在和不存在芯片的情况下,老化小鼠大脑和多谷氨酰胺神经退行性疾病小鼠模型的基础和适应性PQC变化。更多的研究将确定大脑中芯片连接酶复合体的调节机制。拟议的研究将确定作用于中枢神经系统异常折叠蛋白的关键PQC成分,并提供对其作用机制的见解。这一结果有望为一系列与年龄相关的神经退行性疾病的治疗策略提供目标。与公共卫生相关:随着人们年龄的增长,许多常见的、无法治愈的脑部疾病与大脑中异常的蛋白质沉积有关。这项提议试图理解和定义脑细胞内的“质量控制”机制,该机制可以抵消这些异常蛋白质。了解这一机制可能会为治疗随着年龄增长而发生的大量散发性和遗传性神经退行性疾病提供途径。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Henry L Paulson其他文献

Technology Insight: therapeutic RNA interference—how far from the neurology clinic?
技术洞察:治疗性 RNA 干扰——距离神经学临床还有多远?
  • DOI:
    10.1038/ncpneuro0551
  • 发表时间:
    2007-07-01
  • 期刊:
  • 影响因子:
    33.100
  • 作者:
    Pedro Gonzalez-Alegre;Henry L Paulson
  • 通讯作者:
    Henry L Paulson

Henry L Paulson的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Henry L Paulson', 18)}}的其他基金

Michigan Alzheimer's Disease Research Center
密歇根阿尔茨海默病研究中心
  • 批准号:
    10663286
  • 财政年份:
    2021
  • 资助金额:
    $ 29.42万
  • 项目类别:
Core A: Administrative Core
核心A:行政核心
  • 批准号:
    10906471
  • 财政年份:
    2021
  • 资助金额:
    $ 29.42万
  • 项目类别:
Core A: Administrative Core
核心A:行政核心
  • 批准号:
    10261109
  • 财政年份:
    2021
  • 资助金额:
    $ 29.42万
  • 项目类别:
Michigan Alzheimer’s Disease Research Center-Supplement
密歇根阿尔茨海默病研究中心增刊
  • 批准号:
    10599387
  • 财政年份:
    2021
  • 资助金额:
    $ 29.42万
  • 项目类别:
Research Education Component
研究教育部分
  • 批准号:
    10663310
  • 财政年份:
    2021
  • 资助金额:
    $ 29.42万
  • 项目类别:
Michigan Alzheimer's Disease Research Center
密歇根阿尔茨海默病研究中心
  • 批准号:
    10473806
  • 财政年份:
    2021
  • 资助金额:
    $ 29.42万
  • 项目类别:
Mechanisms of neurodegenerative diseases: intersections with ubiquitin pathways
神经退行性疾病的机制:与泛素通路的交叉
  • 批准号:
    10396120
  • 财政年份:
    2021
  • 资助金额:
    $ 29.42万
  • 项目类别:
Core A: Administrative Core
核心A:行政核心
  • 批准号:
    10663287
  • 财政年份:
    2021
  • 资助金额:
    $ 29.42万
  • 项目类别:
Mechanisms of neurodegenerative diseases: intersections with ubiquitin pathways
神经退行性疾病的机制:与泛素通路的交叉
  • 批准号:
    10619544
  • 财政年份:
    2021
  • 资助金额:
    $ 29.42万
  • 项目类别:
Research Education Component
研究教育部分
  • 批准号:
    10473841
  • 财政年份:
    2021
  • 资助金额:
    $ 29.42万
  • 项目类别:

相似海外基金

Hormone therapy, age of menopause, previous parity, and APOE genotype affect cognition in aging humans.
激素治疗、绝经年龄、既往产次和 APOE 基因型会影响老年人的认知。
  • 批准号:
    495182
  • 财政年份:
    2023
  • 资助金额:
    $ 29.42万
  • 项目类别:
Investigating how alternative splicing processes affect cartilage biology from development to old age
研究选择性剪接过程如何影响从发育到老年的软骨生物学
  • 批准号:
    2601817
  • 财政年份:
    2021
  • 资助金额:
    $ 29.42万
  • 项目类别:
    Studentship
RAPID: Coronavirus Risk Communication: How Age and Communication Format Affect Risk Perception and Behaviors
RAPID:冠状病毒风险沟通:年龄和沟通方式如何影响风险认知和行为
  • 批准号:
    2029039
  • 财政年份:
    2020
  • 资助金额:
    $ 29.42万
  • 项目类别:
    Standard Grant
Neighborhood and Parent Variables Affect Low-Income Preschool Age Child Physical Activity
社区和家长变量影响低收入学龄前儿童的身体活动
  • 批准号:
    9888417
  • 财政年份:
    2019
  • 资助金额:
    $ 29.42万
  • 项目类别:
The affect of Age related hearing loss for cognitive function
年龄相关性听力损失对认知功能的影响
  • 批准号:
    17K11318
  • 财政年份:
    2017
  • 资助金额:
    $ 29.42万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
  • 批准号:
    9320090
  • 财政年份:
    2017
  • 资助金额:
    $ 29.42万
  • 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
  • 批准号:
    10166936
  • 财政年份:
    2017
  • 资助金额:
    $ 29.42万
  • 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
  • 批准号:
    9761593
  • 财政年份:
    2017
  • 资助金额:
    $ 29.42万
  • 项目类别:
How age dependent molecular changes in T follicular helper cells affect their function
滤泡辅助 T 细胞的年龄依赖性分子变化如何影响其功能
  • 批准号:
    BB/M50306X/1
  • 财政年份:
    2014
  • 资助金额:
    $ 29.42万
  • 项目类别:
    Training Grant
Inflamm-aging: What do we know about the effect of inflammation on HIV treatment and disease as we age, and how does this affect our search for a Cure?
炎症衰老:随着年龄的增长,我们对炎症对艾滋病毒治疗和疾病的影响了解多少?这对我们寻找治愈方法有何影响?
  • 批准号:
    288272
  • 财政年份:
    2013
  • 资助金额:
    $ 29.42万
  • 项目类别:
    Miscellaneous Programs
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了